Trials / Completed
CompletedNCT05272228
Comparative Single-dose Bioavailability Clinical Study of Different Coenzyme Q10 Products
The Single-centre, Randomized, Comparative Single-dose Bioavailability Clinical Study of Different Coenzyme Q10 Products
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- University of Primorska · Academic / Other
- Sex
- All
- Age
- 40 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The randomized, open-label, three period crossover single-dose bioavailability study with three coenzyme Q10 products
Detailed description
The randomized, open-label, three period crossover single-dose bioavailability study with three coenzyme Q10 products will include 25 subjects who will test three different coenzyme Q10 products. Serum concentration of coenzyme Q10 will be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Dietary supplement - standard product | Single dose intervention with Standard product Coenzyme Q10 (ubiquinone) 2 capsules - 100 mg total coenzyme Q10 |
| DIETARY_SUPPLEMENT | Dietary supplement - Investigational product IP1 | Single dose intervention with Investigational product IP1; Q10 MICROENCAPSULATED 2 capsules - 100 mg total coenzyme Q10 |
| DIETARY_SUPPLEMENT | Dietary supplement - Investigational product IP2 | Single dose intervention with Investigational product IP2; Final formulated product BQSM® 2 capsules - 100 mg total coenzyme Q10 |
Timeline
- Start date
- 2022-03-09
- Primary completion
- 2022-05-15
- Completion
- 2022-07-15
- First posted
- 2022-03-09
- Last updated
- 2022-07-21
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT05272228. Inclusion in this directory is not an endorsement.